471 related articles for article (PubMed ID: 29872619)
1. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.
Li R; He Y; Zhang S; Qin J; Wang J
Acta Pharm Sin B; 2018 Jan; 8(1):14-22. PubMed ID: 29872619
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.
Xia Q; Zhang Y; Li Z; Hou X; Feng N
Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529
[TBL] [Abstract][Full Text] [Related]
3. Biomimetic nanoparticles for inflammation targeting.
Jin K; Luo Z; Zhang B; Pang Z
Acta Pharm Sin B; 2018 Jan; 8(1):23-33. PubMed ID: 29872620
[TBL] [Abstract][Full Text] [Related]
4. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
[TBL] [Abstract][Full Text] [Related]
5. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
6. Cancer cell membrane-coated biomimetic platform for targeted therapy of breast cancer in an orthotopic mouse model.
Han L; Xu Y; Guo X; Yuan C; Mu D; Xiao Y
J Biomater Sci Polym Ed; 2020 Aug; 31(12):1538-1551. PubMed ID: 32362234
[TBL] [Abstract][Full Text] [Related]
7. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.
Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S
J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274
[TBL] [Abstract][Full Text] [Related]
9. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
Cherukula K; Uthaman S; Park IK
Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
[TBL] [Abstract][Full Text] [Related]
10. Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.
Ye S; Wang F; Fan Z; Zhu Q; Tian H; Zhang Y; Jiang B; Hou Z; Li Y; Su G
ACS Appl Mater Interfaces; 2019 May; 11(17):15262-15275. PubMed ID: 30964624
[TBL] [Abstract][Full Text] [Related]
11. Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor.
Siddique AR; Bhagwat GS
Adv Pharm Bull; 2024 Mar; 14(1):132-146. PubMed ID: 38585450
[TBL] [Abstract][Full Text] [Related]
12. Biomacromolecules as carriers in drug delivery and tissue engineering.
Zhang Y; Sun T; Jiang C
Acta Pharm Sin B; 2018 Jan; 8(1):34-50. PubMed ID: 29872621
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic cell membrane-coated poly(lactic-
Jan N; Madni A; Khan S; Shah H; Akram F; Khan A; Ertas D; Bostanudin MF; Contag CH; Ashammakhi N; Ertas YN
Bioeng Transl Med; 2023 Mar; 8(2):e10441. PubMed ID: 36925703
[TBL] [Abstract][Full Text] [Related]
14. Bioresponsive functional nanogels as an emerging platform for cancer therapy.
Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z
Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103
[TBL] [Abstract][Full Text] [Related]
15. Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer.
Zhang L; Li R; Chen H; Wei J; Qian H; Su S; Shao J; Wang L; Qian X; Liu B
Int J Nanomedicine; 2017; 12():2129-2142. PubMed ID: 28360520
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
[TBL] [Abstract][Full Text] [Related]
17. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
18. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cell delivery and cell membrane camouflaged PLGA nanoparticles in the delivery of shikonin for colorectal cancer treatment.
Zhou J; Jiang Z; Sun R; Pan D; Du Q; Zhou X; Chen Y; Chen Y; Peng J
Colloids Surf B Biointerfaces; 2024 Jun; 241():114017. PubMed ID: 38865869
[TBL] [Abstract][Full Text] [Related]
20. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]